Bristol-Myers Squibb ( (BMY) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bristol-Myers Squibb’s stock is on the rise, primarily driven by ongoing clinical trial adjustments and regulatory consultations, which have led to a consensus rating of Moderate Buy. Additionally, Goldman Sachs has increased its price target to $57, influenced by positive interim data analysis and continued patient enrollment in the ADEPT-2 study.
More about Bristol-Myers Squibb
YTD Price Performance: -8.72%
Average Trading Volume: 15,680,358
Technical Sentiment Signal: Buy
Current Market Cap: $100.1B
For further insights into BMY stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.